![](/img/cover-not-exists.png)
Predictive value of activated tyrosine kinase (Tyr1248) in patients with HER2-overexpressing metastatic breast cancer (MBC) treated with trastuzumab + chemotherapy regimens
R Giuliani, M Paesmans, V Durbecq, A Di Leo, D Larsimont, V Cocquyt, F Majois, C Sotiriou, M.J Piccart, F CardosoVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)91006-3
File:
PDF, 329 KB
english, 2004